Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$555M |
| 2 |
Citigroup
C
|
+$407M |
| 3 |
Medtronic
MDT
|
+$401M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$392M |
| 5 |
Gilead Sciences
GILD
|
+$362M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.43B |
| 2 |
Amazon
AMZN
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$1.1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 5 |
Bank of America
BAC
|
+$726M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 83.47% |
| 2 | Technology | 3.02% |
| 3 | Healthcare | 2.92% |
| 4 | Consumer Discretionary | 2.17% |
| 5 | Financials | 2.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
PZC
10776
DELISTED
PIMCO California Municipal Income Fund III
PZC
| $122K | ﹤0.01% |
+16,291
| New | +$119K |
2024 Q3
0 quarters
|
|
|
SEM
10777
CALL
DELISTED
Select Medical
SEM
| $122K | ﹤0.01% |
6,496
+2,598
| +67% | +$49.8K |
2022 Q4
7 quarters
|
|
|
NBP
10778
NovaBridge Biosciences American Depositary Shares
NBP
$155M
| $122K | ﹤0.01% |
98,389
+59,681
| +154% | +$74.7K |
2024 Q2
1 quarter
|
|
10779
PUT
Vanguard Global ex-US Real Estate ETF
VNQI
$3.22B
| $122K | ﹤0.01% |
2,600
+2,000
| +333% | +$87.1K |
2023 Q3
4 quarters
|
|
10780
PUT
KNOT Offshore Partners
KNOP
$358M
| $122K | ﹤0.01% |
17,800
-8,000
| -31% | -$57.6K |
2022 Q3
8 quarters
|
|
10781
Nicolet Bankshares
NIC
$3.39B
| $122K | ﹤0.01% |
1,273
+74
| +6% | +$6.92K |
2023 Q3
4 quarters
|
|
10782
PUT
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.4B
| $122K | ﹤0.01% |
500
-1,600
| -76% | -$373K |
2021 Q2
13 quarters
|
|
10783
PUT
Cambria Tail Risk ETF
TAIL
$147M
| $122K | ﹤0.01% |
+10,100
| New | +$121K |
2024 Q3
0 quarters
|
|
10784
CALL
Texas Capital Bancshares
TCBI
$3.88B
| $121K | ﹤0.01% |
1,700
+600
| +55% | +$39.3K |
2020 Q2
17 quarters
|
|
10785
PUT
Colliers International
CIGI
$4.36B
| $121K | ﹤0.01% |
800
+100
| +14% | +$13.6K |
2022 Q4
7 quarters
|
|
10786
Kaltura
KLTR
$201M
| $121K | ﹤0.01% |
89,197
-103,563
| -54% | -$127K |
2023 Q1
6 quarters
|
|
|
SAGE
10787
PUT
DELISTED
Sage Therapeutics
SAGE
| $121K | ﹤0.01% |
16,800
-21,500
| -56% | -$197K |
2016 Q2
33 quarters
|
|
|
PMO
10788
Franklin Municipal Opportunities Trust
PMO
$252M
| $121K | ﹤0.01% |
+11,117
| New | +$117K |
2024 Q3
0 quarters
|
|
10789
CALL
HUTCHMED
HCM
$2.36B
| $121K | ﹤0.01% |
6,200
+2,400
| +63% | +$43.4K |
2022 Q4
7 quarters
|
|
|
MVF
10790
DELISTED
BlackRock MuniVest Fund
MVF
| $121K | ﹤0.01% |
+15,920
| New | +$118K |
2024 Q3
0 quarters
|
|
|
CBL
10791
PUT
CBL Properties
CBL
$1.51B
| $121K | ﹤0.01% |
4,800
-9,900
| -67% | -$251K |
2022 Q3
8 quarters
|
|
|
ACR
10792
ACRES Commercial Realty
ACR
$159M
| $121K | ﹤0.01% |
7,723
-2,352
| -23% | -$35.1K |
2024 Q1
2 quarters
|
|
|
GP
10793
GreenPower Motor Co
GP
$3.68M
| $121K | ﹤0.01% |
8,811
+7,282
| +476% | +$79.6K |
2023 Q4
3 quarters
|
|
10794
PUT
Direxion Daily MSCI India Bull 2X ETF
INDL
$46.9M
| $121K | ﹤0.01% |
1,600
+1,000
| +167% | +$72.4K |
2023 Q3
4 quarters
|
|
10795
CALL
Healthcare Services Group
HCSG
$1.41B
| $121K | ﹤0.01% |
10,800
+8,500
| +370% | +$93.3K |
2022 Q4
7 quarters
|
|
10796
ProShares Ultra NASDAQ Biotechnology
BIB
$85.7M
| $121K | ﹤0.01% |
1,892
-7,080
| -79% | -$457K |
2024 Q2
1 quarter
|
|
10797
CALL
Pediatrix Medical
MD
$2.09B
| $121K | ﹤0.01% |
10,400
-11,400
| -52% | -$107K |
2022 Q3
8 quarters
|
|
10798
PUT
Varex Imaging
VREX
$783M
| $120K | ﹤0.01% |
10,100
+8,600
| +573% | +$110K |
2023 Q2
5 quarters
|
|
10799
PUT
Korn Ferry
KFY
$3.97B
| $120K | ﹤0.01% |
1,600
-1,600
| -50% | -$112K |
2022 Q4
7 quarters
|
|
|
INVX
10800
PUT
Innovex International
INVX
$1.89B
| $120K | ﹤0.01% |
8,200
+5,800
| +242% | +$93.1K |
2022 Q4
7 quarters
|
|
Similar funds
Citadel Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, Citadel Advisors held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citadel Advisors's Q3 2024 filing shows 1,612 new, 6,434 increased, 5,866 reduced and 1,610 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 82% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
- Citadel Advisors added most to NVIDIA in Q3 2024, an estimated $555M increase.
- Citadel Advisors's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
- Citadel Advisors fully exited Domino's in Q3 2024, selling an estimated $186M.
- Citadel Advisors's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
- Citadel Advisors opened 1,612 new positions and closed 1,610 in Q3 2024.
- Citadel Advisors's portfolio value rose 4.9% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.